Milrinone (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Milrinone" in English language version.

refsWebsite

Global rank English rank

19nih.gov

4^th place

15doi.org

2^nd place

5espacenet.com

800^th place

676^th place

4semanticscholar.org

11^th place

8^th place

2drugs.com

399^th place

333^rd place

1europa.eu

68^th place

117^th place

1harvard.edu

18^th place

17^th place

1sciencedirect.com

149^th place

178^th place

1patents.google.com

1,182^nd place

725^th place

doi.org

Baxter FJ, Whippey A (November 2020). "Amniotic Fluid Embolism Treated With Inhaled Milrinone: A Case Report". A&A Practice. 14 (13): e01342. doi:10.1213/XAA.0000000000001342. PMID 33185413. S2CID 226851766.
Packer M (December 1990). "Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy". Circulation. 82 (6): 2254–2257. doi:10.1161/01.cir.82.6.2254. PMID 2242549. S2CID 11255642.
Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al. (November 1991). "Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group". The New England Journal of Medicine. 325 (21): 1468–1475. doi:10.1056/NEJM199111213252103. PMID 1944425.
Fleming GA, Murray KT, Yu C, Byrne JG, Greelish JP, Petracek MR, et al. (October 2008). "Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery". Circulation. 118 (16): 1619–1625. doi:10.1161/CIRCULATIONAHA.108.790162. PMC 2770257. PMID 18824641.
Koster G, Bekema HJ, Wetterslev J, Gluud C, Keus F, van der Horst IC (September 2016). "Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis". Intensive Care Medicine. 42 (9): 1322–1335. doi:10.1007/s00134-016-4449-6. PMC 4992029. PMID 27448246.
de Tombe PP (February 1998). "Altered contractile function in heart failure". Cardiovascular Research. 37 (2): 367–380. doi:10.1016/s0008-6363(97)00275-7. PMID 9614494.
Ward ML, Crossman DJ (July 2014). "Mechanisms underlying the impaired contractility of diabetic cardiomyopathy". World Journal of Cardiology. 6 (7): 577–584. doi:10.4330/wjc.v6.i7.577. PMC 4110606. PMID 25068018.
Szent-Györgyi AG (July 1975). "Calcium regulation of muscle contraction". Biophysical Journal. 15 (7): 707–723. Bibcode:1975BpJ....15..707S. doi:10.1016/S0006-3495(75)85849-8. PMC 1334730. PMID 806311.
Zimmerman J, Cahalan M (January 2013). "Chapter 22 - Vasopressors and Inotropes". In Hemmings HC, Egan TD (eds.). Pharmacology and Physiology for Anesthesia. Philadelphia: W.B. Saunders. pp. 390–404. doi:10.1016/B978-1-4377-1679-5.00022-3. ISBN 978-1-4377-1679-5. S2CID 79282649. Retrieved 2023-03-14.
McNamara PJ, Shivananda SP, Sahni M, Freeman D, Taddio A (January 2013). "Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide". Pediatric Critical Care Medicine. 14 (1): 74–84. doi:10.1097/PCC.0b013e31824ea2cd. PMID 23132395. S2CID 7696208.
Hui-li G (June 2011). "The management of acute pulmonary arterial hypertension". Cardiovascular Therapeutics. 29 (3): 153–175. doi:10.1111/j.1755-5922.2009.00095.x. PMID 20560976.
Beute J, Lukkes M, Koekoek EP, Nastiti H, Ganesh K, de Bruijn MJ, et al. (January 2018). "A pathophysiological role of PDE3 in allergic airway inflammation". JCI Insight. 3 (2). doi:10.1172/jci.insight.94888. PMC 5821178. PMID 29367458.
Arbeus M, Axelsson B, Friberg O, Magnuson A, Bodin L, Hultman J (February 2009). "Milrinone increases flow in coronary artery bypass grafts after cardiopulmonary bypass: a prospective, randomized, double-blind, placebo-controlled study". Journal of Cardiothoracic and Vascular Anesthesia. 23 (1). Elsevier BV: 48–53. doi:10.1053/j.jvca.2008.07.005. PMID 18834820.
Singh B (1985). "A Novel Synthesis of 1,6-Dihydro-2-methyl-6-oxo[3,4'-bipyridine]-5-carbonitrile (Milrinone)". Heterocycles. 23 (6): 1479. doi:10.3987/R-1985-06-1479.
Shiao MJ, Shyu LM, Chen CF (1990). "Synthesis of Milrinone, a Cardiotonic Agent". Heterocycles. 31 (3): 523. doi:10.3987/COM-89-5276.

drugs.com

"Milrinone Dosage Guide + Max Dose, Adjustments". Drugs.com. Retrieved 2023-01-03.
"Milrinone Lactate Monograph". drugs.com.

espacenet.com

worldwide.espacenet.com

US 4264603, Lesher GY, Gruett MD, issued 1981, assigned to Sterling Drug Inc.
US 4413127, Singh B, issued 1983, assigned to Sterling
CN 104326975, Yan H, Deng A, "Preparation method of high-purity milrinone", issued 2015, assigned to ZHENGZHOU SIHUAN MEDICINE ARTICLE Co Ltd
CN 104387320, Ao L, Zhang B, Pan J, Chen Y, "Preparation Method for High-Purity Milrinone", issued 2018, assigned to Huzhou Zhanwang Pharmaceutical Co., Ltd.
CN 103848779, Tan X, Jing Y, Wang F, Liu H, Yu U, "Preparation method of 1-(4-pyridyl) acetone", issued 2014, assigned to University of Jinan

europa.eu

ema.europa.eu

"Active substance: milrinone" (PDF). List of nationally authorised medicinal products. European Medicines Agency. 10 June 2022.

harvard.edu

ui.adsabs.harvard.edu

Szent-Györgyi AG (July 1975). "Calcium regulation of muscle contraction". Biophysical Journal. 15 (7): 707–723. Bibcode:1975BpJ....15..707S. doi:10.1016/S0006-3495(75)85849-8. PMC 1334730. PMID 806311.

nih.gov

pubmed.ncbi.nlm.nih.gov

Baxter FJ, Whippey A (November 2020). "Amniotic Fluid Embolism Treated With Inhaled Milrinone: A Case Report". A&A Practice. 14 (13): e01342. doi:10.1213/XAA.0000000000001342. PMID 33185413. S2CID 226851766.
Packer M (December 1990). "Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy". Circulation. 82 (6): 2254–2257. doi:10.1161/01.cir.82.6.2254. PMID 2242549. S2CID 11255642.
Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al. (November 1991). "Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group". The New England Journal of Medicine. 325 (21): 1468–1475. doi:10.1056/NEJM199111213252103. PMID 1944425.
Fleming GA, Murray KT, Yu C, Byrne JG, Greelish JP, Petracek MR, et al. (October 2008). "Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery". Circulation. 118 (16): 1619–1625. doi:10.1161/CIRCULATIONAHA.108.790162. PMC 2770257. PMID 18824641.
Koster G, Bekema HJ, Wetterslev J, Gluud C, Keus F, van der Horst IC (September 2016). "Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis". Intensive Care Medicine. 42 (9): 1322–1335. doi:10.1007/s00134-016-4449-6. PMC 4992029. PMID 27448246.
de Tombe PP (February 1998). "Altered contractile function in heart failure". Cardiovascular Research. 37 (2): 367–380. doi:10.1016/s0008-6363(97)00275-7. PMID 9614494.
Ward ML, Crossman DJ (July 2014). "Mechanisms underlying the impaired contractility of diabetic cardiomyopathy". World Journal of Cardiology. 6 (7): 577–584. doi:10.4330/wjc.v6.i7.577. PMC 4110606. PMID 25068018.
Szent-Györgyi AG (July 1975). "Calcium regulation of muscle contraction". Biophysical Journal. 15 (7): 707–723. Bibcode:1975BpJ....15..707S. doi:10.1016/S0006-3495(75)85849-8. PMC 1334730. PMID 806311.
King J, Lowery DR (2022). "Physiology, Cardiac Output". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29262215.
McNamara PJ, Shivananda SP, Sahni M, Freeman D, Taddio A (January 2013). "Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide". Pediatric Critical Care Medicine. 14 (1): 74–84. doi:10.1097/PCC.0b013e31824ea2cd. PMID 23132395. S2CID 7696208.
Hui-li G (June 2011). "The management of acute pulmonary arterial hypertension". Cardiovascular Therapeutics. 29 (3): 153–175. doi:10.1111/j.1755-5922.2009.00095.x. PMID 20560976.
Beute J, Lukkes M, Koekoek EP, Nastiti H, Ganesh K, de Bruijn MJ, et al. (January 2018). "A pathophysiological role of PDE3 in allergic airway inflammation". JCI Insight. 3 (2). doi:10.1172/jci.insight.94888. PMC 5821178. PMID 29367458.
Arbeus M, Axelsson B, Friberg O, Magnuson A, Bodin L, Hultman J (February 2009). "Milrinone increases flow in coronary artery bypass grafts after cardiopulmonary bypass: a prospective, randomized, double-blind, placebo-controlled study". Journal of Cardiothoracic and Vascular Anesthesia. 23 (1). Elsevier BV: 48–53. doi:10.1053/j.jvca.2008.07.005. PMID 18834820.

ncbi.nlm.nih.gov

Fleming GA, Murray KT, Yu C, Byrne JG, Greelish JP, Petracek MR, et al. (October 2008). "Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery". Circulation. 118 (16): 1619–1625. doi:10.1161/CIRCULATIONAHA.108.790162. PMC 2770257. PMID 18824641.
Koster G, Bekema HJ, Wetterslev J, Gluud C, Keus F, van der Horst IC (September 2016). "Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis". Intensive Care Medicine. 42 (9): 1322–1335. doi:10.1007/s00134-016-4449-6. PMC 4992029. PMID 27448246.
Ward ML, Crossman DJ (July 2014). "Mechanisms underlying the impaired contractility of diabetic cardiomyopathy". World Journal of Cardiology. 6 (7): 577–584. doi:10.4330/wjc.v6.i7.577. PMC 4110606. PMID 25068018.
Szent-Györgyi AG (July 1975). "Calcium regulation of muscle contraction". Biophysical Journal. 15 (7): 707–723. Bibcode:1975BpJ....15..707S. doi:10.1016/S0006-3495(75)85849-8. PMC 1334730. PMID 806311.
King J, Lowery DR (2022). "Physiology, Cardiac Output". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29262215.
Beute J, Lukkes M, Koekoek EP, Nastiti H, Ganesh K, de Bruijn MJ, et al. (January 2018). "A pathophysiological role of PDE3 in allergic airway inflammation". JCI Insight. 3 (2). doi:10.1172/jci.insight.94888. PMC 5821178. PMID 29367458.

patents.google.com

BE886336 idem G. Y. Lesher, R. E. Philion, U.S. patent 4,313,951 (1982 both to Sterling).

sciencedirect.com

Zimmerman J, Cahalan M (January 2013). "Chapter 22 - Vasopressors and Inotropes". In Hemmings HC, Egan TD (eds.). Pharmacology and Physiology for Anesthesia. Philadelphia: W.B. Saunders. pp. 390–404. doi:10.1016/B978-1-4377-1679-5.00022-3. ISBN 978-1-4377-1679-5. S2CID 79282649. Retrieved 2023-03-14.

semanticscholar.org

api.semanticscholar.org

Baxter FJ, Whippey A (November 2020). "Amniotic Fluid Embolism Treated With Inhaled Milrinone: A Case Report". A&A Practice. 14 (13): e01342. doi:10.1213/XAA.0000000000001342. PMID 33185413. S2CID 226851766.
Packer M (December 1990). "Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy". Circulation. 82 (6): 2254–2257. doi:10.1161/01.cir.82.6.2254. PMID 2242549. S2CID 11255642.
Zimmerman J, Cahalan M (January 2013). "Chapter 22 - Vasopressors and Inotropes". In Hemmings HC, Egan TD (eds.). Pharmacology and Physiology for Anesthesia. Philadelphia: W.B. Saunders. pp. 390–404. doi:10.1016/B978-1-4377-1679-5.00022-3. ISBN 978-1-4377-1679-5. S2CID 79282649. Retrieved 2023-03-14.
McNamara PJ, Shivananda SP, Sahni M, Freeman D, Taddio A (January 2013). "Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide". Pediatric Critical Care Medicine. 14 (1): 74–84. doi:10.1097/PCC.0b013e31824ea2cd. PMID 23132395. S2CID 7696208.